Nepal | August 04, 2020

China’s CanSino in talks for COVID-19 vaccine Phase III trial overseas

REUTERS
Share Now:

SUZHOU/BEIJING: Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday.

China‘s success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countries have agreed to work with it.

“We are contacting Russia, Brazil, Chile and Saudi Arabia (for the Phase III trial), and it’s still in discussion,” Qiu Dongxu, executive director and co-founder of CanSino, told an anti-viral drug development conference in Suzhou, in eastern China.

He said its Phase III trial was likely to start “pretty soon,” and the company plans to recruit 40,000 participants for the test.

Its COVID-19 candidate, Ad5-nCov, became the first in China to move into human testing in March but is running behind other potential vaccines in terms of trial progress. Two experimental vaccines developed by Sinovac Biotech and a unit of China National Pharmaceutical Group (Sinopharm) are already approved for Phase III trials.

Qiu said its Phase II trial involving 508 people has yielded “much better” results than the Phase I about the safety and ability to trigger immune response. He did not disclose specific evidence.

He said its new factory under construction in China will allow it to produce 100-200 million doses of coronavirus vaccines per year by early 2021.

China‘s military, whose research unit is co-developing the vaccine candidate, approved its military use last month, while Sinopharm’s two experimental shots are offered to employees at state-owned firms travelling overseas.

Zeng Guang, former chief epidemiologist at the Chinese Center for Disease Control and Prevention, told the conference that Chinese construction groups overseas in particular are keen to take experimental vaccines.

He also said discussion should start whether to launch emergency inoculation of experimental vaccines “right now.”

There are no approved vaccines yet for COVID-19, a respiratory disease caused by the new coronavirus, which has killed more than half a million people globally.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

NASA astronauts make historic return home aboard SpaceX capsule

US astronauts Bob Behnken and Doug Hurley, who flew to the International Space Station in SpaceX's new Crew Dragon, splashed down in the capsule in the Gulf of Mexico on Sunday after a two-month voyage that was NASA's first crewed mission from home soil in nine years. Behnken and Hurley, Read More...

Media urged to refrain from brewing controversy over court verdict, order

Media criticism of verdicts erodes faith in the judiciary Kathmandu, August 2 Nepal Bar Association today issued a press release urging media outlets to maintain restraint about court verdicts. It also said a court should not pass an order or a verdict that creates controversy. “NBA’s ser Read More...

TUTH. Tribhuvan University Teaching Hospital, Teaching Hospital, Maharajgunj

COVID patient recovers after plasma therapy

KATHMANDU, AUGUST 2 Plasma therapy was used for the first time in the country to successfully treat a 60-year-old coronavirus patient, in Kathmandu, earlier this week. The procedure was performed at Tribhuvan University Teaching Hospital, Maharajgunj. “The patient, a resident of Biratnagar, Read More...

Call to grant rights to reopen schools to local levels

Kathmandu, August 2 The government has been advised to come up with a procedure to pass on the right to reopen schools that have remained closed due to the COVID-19, to respective local governments and schools. While Ministry of Education, Science and Technology is preparing to bring a work pr Read More...

‘People’s voice will be suppressed if journalists lose their jobs’

Kaski, August 2 President of Federation of Nepali Journalists Govinda Acharya said actions such as relieving journalists of their jobs, providing half salary and exerting pressure on them to stay on leave without payment would suppress the voice of the people. During an interaction here today, Read More...

25 per cent tourism workers return to work

Pokhara, August 2 After relaxation of the lockdown to contain COVID-19, normalcy is beginning to return in the tourism sector with workers in this sector starting to return to work after four months of shutdown. Pokhara Tourism Council said 25 per cent workers associated with the tourism indus Read More...

Police vital for ensuring peace: CM Gurung

Pokhara, August 2 Gandaki Province Chief Minister Prithivi Subba Gurung today said that Gandaki Province Police Office had to play a significant role in enforcing peace and controlling crime. CM Gurung handed over keys of vehicles provided by the provincial government to Gandaki Province P Read More...

Snakebite patients up in Bheri Hospital

Nepalgunj, August 2 The number of snakebite patients has increased in Nepalgunj-based Bheri Hospital of late. Snakebite patients were admitted to the emergency and ICU wards after their numbers surged with the beginning of monsoon. As many as 10 to 15 snakebite patients reach the hospital f Read More...